Adapalene/ Benzoyl Peroxide (Epiduo)
Is It Right for You?
A complete guide to Adapalene/Benzoyl Peroxide (Epiduo) — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Epiduo (Adapalene / Benzoyl Peroxide)?
Epiduo is a fixed-dose combination topical gel containing two complementary active ingredients: adapalene 0.1% (a third-generation synthetic retinoid) and benzoyl peroxide 2.5%. It is manufactured by Galderma and is one of the most clinically well-evidenced topical treatments for acne vulgaris available in the UK. A stronger formulation, Epiduo Forte, contains adapalene 0.3% combined with benzoyl peroxide 2.5%, and is reserved for more severe or treatment-resistant cases.
The rationale for combining adapalene and benzoyl peroxide in a single preparation is based on their distinct and complementary mechanisms of action: adapalene targets the abnormal follicular keratinisation and inflammation that initiate acne lesions, while benzoyl peroxide provides potent bactericidal activity against Cutibacterium acnes (formerly Propionibacterium acnes), the bacteria central to acne pathogenesis. Together, they address multiple disease pathways simultaneously — a strategy that produces superior efficacy to either agent used alone.
Epiduo is supplied as a white to off-white gel in pump or tube presentations. It requires a prescription in the UK, though adapalene 0.1% gel alone is available over the counter (Differin) at reduced potency without the addition of benzoyl peroxide.
What Conditions Does Epiduo Treat?
Epiduo is indicated for
Epiduo is specifically licensed for the topical treatment of acne vulgaris when comedones (blackheads and whiteheads), papules, and pustules are present. It is suitable for facial, chest, and back acne. Clinical trials have demonstrated statistically and clinically significant reductions in both inflammatory lesions (papules and pustules) and non-inflammatory lesions (open and closed comedones) compared with either monotherapy or vehicle alone.
Epiduo is appropriate for mild-to-moderate acne as a first-line or second-line topical treatment, and may be used as part of a broader regimen including topical or oral antibiotics, or hormonal treatments in appropriate patients.
Because adapalene is a potent comedolytic agent — it normalises follicular keratinocyte differentiation and prevents comedone formation — Epiduo is particularly effective in acne presentations dominated by non-inflammatory lesions (open and closed comedones), including those in younger patients with early-stage acne.
A key advantage of Epiduo over antibiotic-containing preparations is that benzoyl peroxide does not induce antibiotic resistance. Current UK (NICE) and international (EDF, AAD) guidelines recommend that topical and oral antibiotic acne treatments should always be accompanied by benzoyl peroxide to reduce the risk of antibiotic resistance. Epiduo is therefore well-suited to patients with known resistant C. acnes strains or as a maintenance therapy after completing a course of oral antibiotics.
Epiduo is an antibiotic with no effect on viruses. It will not treat colds, influenza, COVID-19, or other viral illnesses. Inappropriate use contributes to antibiotic resistance and should be avoided.
How Does Epiduo Work?
Adapalene (Retinoid Component)
Adapalene is a naphthoic acid derivative that binds selectively to nuclear retinoic acid receptors (RAR-beta and RAR-gamma). This receptor binding modulates gene expression in keratinocytes, normalising their proliferation and differentiation within the follicular canal. The practical effect is a reduction in microcomedone formation — the primary initiating event in all forms of acne vulgaris — by preventing the abnormal compaction and retention of dead skin cells that block follicular pores.
In addition to its comedolytic properties, adapalene has significant anti-inflammatory activity. It inhibits the activation of toll-like receptors (TLR-2) on keratinocytes, reduces the production of pro-inflammatory cytokines (IL-1, IL-8), and blunts the early inflammatory cascade that converts microcomedones into papules and pustules. Third-generation adapalene is better tolerated than older retinoids (tretinoin, isotretinoin topical) with less irritancy and greater photostability.
Benzoyl Peroxide (Antibacterial Component)
Benzoyl peroxide is a potent oxidising agent that releases free oxygen radicals into the follicular environment. These radicals are directly bactericidal against C. acnes, rapidly reducing the bacterial burden within sebaceous follicles. Benzoyl peroxide also has mild keratolytic (exfoliating) and sebostatic properties. Critically, because its bactericidal mechanism is non-specific oxidative damage rather than targeting a specific bacterial structure, C. acnes does not develop resistance to benzoyl peroxide — making it a cornerstone of both active treatment and antibiotic resistance prevention strategies in acne management.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Side Effects of Epiduo
Epiduo is generally well tolerated, but because it contains a retinoid and benzoyl peroxide, it commonly affects the skin—especially during the first few weeks of treatment.
- Dryness and peeling of the skin
- Redness and irritation
- Burning or stinging sensation
- Increased sensitivity to sunlight (photosensitivity)
- Mild itching
- Severe allergic reaction — swelling of the face, lips, or throat, difficulty breathing
- Severe skin irritation — intense redness, blistering, crusting, or swelling
- Chemical burns or severe inflammation — especially if overused or applied to broken skin
- Extreme sun sensitivity — leading to severe sunburn even with limited exposure
Epiduo can significantly increase skin sensitivity, particularly during the initial weeks of treatment. While mild irritation is expected, excessive use or application on damaged skin can lead to severe inflammation, burning, or chemical irritation. Patients should use a thin layer, avoid broken or eczematous skin, and limit sun exposure, as the medication increases susceptibility to severe sunburn. If marked redness, blistering, or discomfort occurs, treatment should be paused and medical advice sought promptly.
Drug Interactions
Always disclose all prescription drugs, over-the-counter medicines, vitamins, and supplements to your clinician or pharmacist before starting Epiduo
Important Warnings
Benzoyl peroxide will permanently bleach or discolour fabrics, towels, pillowcases, and clothing it comes into contact with. Use white or old towels and pillowcases and allow the gel to dry completely before contact with fabric.
Adapalene increases photosensitivity. Daily SPF 30 or higher broad-spectrum sunscreen is essential throughout treatment. Failure to protect the skin from UV exposure increases the risk of sunburn and may worsen skin irritation.
Some patients experience an apparent increase in spots — commonly called "purging" — during the first 4–6 weeks of retinoid treatment. This occurs because adapalene accelerates the turnover of pre-existing microcomedones, bringing lesions to the surface more rapidly. This is a normal and temporary phenomenon that precedes improvement. Patients should be counselled on this before treatment to avoid premature discontinuation.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Epiduo FAQs
Patients typically begin to see improvement in inflammatory lesions (papules and pustules) after approximately 4 to 8 weeks of consistent use. Non-inflammatory lesions (comedones) and overall skin texture may take longer — full results are usually seen at 12 weeks. Clinical trials measure outcomes at 12 weeks, which should be communicated to patients at the outset to set realistic expectations and prevent early discontinuation.
Yes, and it is strongly recommended, particularly during the initial weeks of treatment. A simple, non-comedogenic, fragrance-free moisturiser should be applied daily to counteract the drying and barrier-disrupting effects of treatment. The moisturiser can be applied in the morning, after cleansing, and on the same evening before or after Epiduo as needed. Moisturiser use significantly improves tolerability and reduces early discontinuation rates.
Epiduo can be combined with oral antibiotics (e.g. doxycycline, lymecycline) or combined oral contraceptives (in female patients) under clinician guidance. It should not be used alongside other topical retinoids, and concurrent use of other irritating topical actives (salicylic acid, glycolic acid) should be avoided, particularly during the adjustment phase.
Yes. Epiduo is licensed for use on the face, chest, and back. The same application principles apply — a thin, even layer across the entire affected area, once daily in the evening.
Epiduo effectively controls acne while in use but does not permanently cure it, as it does not address the underlying hormonal or genetic factors predisposing to acne. Many patients require long-term maintenance therapy to sustain results. For patients who achieve good control, a clinician may advise maintenance with adapalene alone (e.g. Differin) or a lower-frequency Epiduo regimen after the active treatment phase.
Yes, though ideally non-comedogenic, oil-free formulations are preferred. Apply Epiduo in the evening after cleansing and allow it to absorb fully before applying any make-up or skincare. In the morning, ensure sunscreen is applied. Avoid heavy occlusive make-up products over treated areas.
Adapalene alone treats acne through its comedolytic and anti-inflammatory actions but has limited antibacterial activity. Benzoyl peroxide adds powerful bactericidal activity against C. acnes, which drives the inflammatory component of acne. Critically, benzoyl peroxide does not cause antibiotic resistance and actually helps prevent the development of resistant C. acnes strains if used alongside antibiotic treatments. The combination in Epiduo is both more efficacious and more resistance-prudent than adapalene or antibiotic monotherapy.